VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage

被引:26
作者
Garcia-Gonzalez, Raul [1 ,2 ]
Morejon-Garcia, Patricia [1 ,2 ]
Campillo-Marcos, Ignacio [1 ,2 ]
Salzano, Marcella [3 ]
Lazo, Pedro A. [1 ,2 ]
机构
[1] CSIC Univ Salamanca, Inst Biol Mol & Celular Canc, Mol Mech Canc Program, Campus Miguel Unamuno, Salamanca 37007, Spain
[2] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Area Canc, Salamanca 37007, Spain
[3] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Vall Hebron Inst Recerca, Enfermedades Digestivas & Hepat, Barcelona 08035, Spain
关键词
phosphorylation; histone H4; acetylation; DNA-damage response; nucleosomal histone kinase-1; KINASE; 1; VRK1; VACCINIA-RELATED KINASE-1; HISTONE ACETYLTRANSFERASE; PROTEASOMAL DEGRADATION; SIGNALING PATHWAY; CHROMATIN; P53; COMPLEX; 53BP1; BINDING;
D O I
10.3390/cancers12102986
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Dynamic remodeling of chromatin requires epigenetic modifications of histones. DNA damage induced by doxorubicin causes an increase in histone H4K16ac, a marker of local chromatin relaxation. We studied the role that VRK1, a chromatin kinase activated by DNA damage, plays in this early step. VRK1 depletion or MG149, a Tip60/KAT5 inhibitor, cause a loss of H4K16ac. DNA damage induces the phosphorylation of Tip60 mediated by VRK1 in the chromatin fraction. VRK1 directly interacts and phosphorylates Tip60. This phosphorylation of Tip60 is lost by depletion of VRK1 in both ATM +/+ and ATM-/- cells. Kinase-active VRK1, but not kinase-dead VRK1, rescues Tip60 phosphorylation induced by DNA damage independently of ATM. The VRK1 chromatin kinase is an upstream regulator of the initial acetylation of histones, and an early step in DNA damage responses. Dynamic remodeling of chromatin requires acetylation and methylation of histones, frequently affecting the same lysine residue. These alternative epigenetic modifications require the coordination of enzymes, writers and erasers, mediating them such as acetylases and deacetylases. In cells in G0/G1, DNA damage induced by doxorubicin causes an increase in histone H4K16ac, a marker of chromatin relaxation. In this context, we studied the role that VRK1, a chromatin kinase activated by DNA damage, plays in this early step. VRK1 depletion or MG149, a Tip60/KAT5 inhibitor, cause a loss of H4K16ac. DNA damage induces the phosphorylation of Tip60 mediated by VRK1 in the chromatin fraction. VRK1 directly interacts with and phosphorylates Tip60. Furthermore, the phosphorylation of Tip60 induced by doxorubicin is lost by depletion of VRK1 in both ATM +/+ and ATM-/- cells. Kinase-active VRK1, but not kinase-dead VRK1, rescues Tip60 phosphorylation induced by DNA damage independently of ATM. The Tip60 phosphorylation by VRK1 is necessary for the activating acetylation of ATM, and subsequent ATM autophosphorylation, and both are lost by VRK1 depletion. These results support that the VRK1 chromatin kinase is an upstream regulator of the initial acetylation of histones, and an early step in DNA damage responses (DDR).
引用
收藏
页码:1 / 24
页数:24
相关论文
共 79 条
  • [1] Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo
    Aihara, H
    Nakagawa, T
    Yasui, K
    Ohta, T
    Hirose, S
    Dhomae, N
    Takio, K
    Kaneko, M
    Takeshima, Y
    Muramatsu, M
    Ito, T
    [J]. GENES & DEVELOPMENT, 2004, 18 (08) : 877 - 888
  • [2] Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1
    Aihara, Hitoshi
    Nakagawa, Takeya
    Mizusaki, Hirofumi
    Yoneda, Mitsuhiro
    Kato, Masanori
    Doiguchi, Masamichi
    Imamura, Yuko
    Higashi, Miki
    Ikura, Tsuyoshi
    Hayashi, Tomonori
    Kodama, Yoshiaki
    Oki, Masaya
    Nakayama, Toshiyuki
    Cheung, Edwin
    Aburatani, Hiroyuki
    Takayama, Ken-ichi
    Koseki, Haruhiko
    Inoue, Satoshi
    Takeshima, Yukio
    Ito, Takashi
    [J]. MOLECULAR CELL, 2016, 64 (01) : 176 - 188
  • [3] Regulation of chromatin by histone modifications
    Bannister, Andrew J.
    Kouzarides, Tony
    [J]. CELL RESEARCH, 2011, 21 (03) : 381 - 395
  • [4] The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
    Beekman, Renee
    Chapaprieta, Vicente
    Russinol, Nuria
    Vilarrasa-Blasi, Roser
    Verdaguer-Dot, Nuria
    Martens, Joost H. A.
    Duran-Ferrer, Marti
    Kulis, Marta
    Serra, Francois
    Javierre, Biola M.
    Wingett, Steven W.
    Clot, Guillem
    Queiros, Ana C.
    Castellano, Giancarlo
    Blanc, Julie
    Gut, Marta
    Merkel, Angelika
    Heath, Simon
    Vlasova, Anna
    Ullrich, Sebastian
    Palumbo, Emilio
    Enjuanes, Anna
    Martin-Garcia, David
    Bea, Silvia
    Pinyol, Magda
    Aymerich, Marta
    Royo, Romina
    Puiggros, Montserrat
    Torrents, David
    Datta, Avik
    Lowy, Ernesto
    Kostadima, Myrto
    Roller, Masa
    Clarke, Laura
    Flicek, Paul
    Agirre, Xabier
    Prosper, Felipe
    Baumann, Tycho
    Delgado, Julio
    Lopez-Guillermo, Armando
    Fraser, Peter
    Yaspo, Marie-Laure
    Guigo, Roderic
    Siebert, Reiner
    Marti-Renom, Marc A.
    Puente, Xose S.
    Lopez-Otin, Carlos
    Gut, Ivo
    Stunnenberg, Hendrik G.
    Campo, Elias
    [J]. NATURE MEDICINE, 2018, 24 (06) : 868 - +
  • [5] Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
    Bowers, Erin M.
    Yan, Gai
    Mukherjee, Chandrani
    Orry, Andrew
    Wang, Ling
    Holbert, Marc A.
    Crump, Nicholas T.
    Hazzalin, Catherine A.
    Liszczak, Glen
    Yuan, Hua
    Larocca, Cecilia
    Saldanha, S. Adrian
    Abagyan, Ruben
    Sun, Yan
    Meyers, David J.
    Marmorstein, Ronen
    Mahadevan, Louis C.
    Alani, Rhoda M.
    Cole, Philip A.
    [J]. CHEMISTRY & BIOLOGY, 2010, 17 (05): : 471 - 482
  • [6] CDK9-mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery
    Brauns-Schubert, Prisca
    Schubert, Florian
    Wissler, Manuela
    Weiss, Martina
    Schlicher, Lisa
    Bessler, Simon
    Safavi, Mariam
    Miething, Cornelius
    Borner, Christoph
    Brummer, Tilman
    Maurer, Ulrich
    [J]. EMBO REPORTS, 2018, 19 (02) : 244 - 256
  • [7] Bremer M., 2009, STAT BENCH STEP BY S
  • [8] Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase
    Campillo-Marcos, Ignacio
    Lazo, Pedro A.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [9] Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
    Campillo-Marcos, Ignacio
    Lazo, Pedro A.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (13) : 2375 - 2388
  • [10] Cantarero L., 2017, VRK1 VACCINIA RELATE, DOI [10.1007/978-1-4614-6438-9_561-2, DOI 10.1007/978-1-4614-6438-9_561-2]